drugset / Trial / NCT02805738
Clinical Trial to Evaluate the Efficacy and Safety of CKD-390 Tablet
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A Multicenter, Randomized, Double-blind, Parallel Design, Phase III Clinical Trial to Evaluate the Efficacy and Safety of CKD-390 tablet
Timeline
- Start
- 2016-04
- Primary completion
- 2017-11
- Completion
- 2018-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CKD-390 | Small molecule | 308.04 mg | Oral |
| Comparator | Tenofovir disoproxil fumarate | Small molecule | 300 mg | Oral |